Katelin A Mirkin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Katelin A Mirkin

Showing results (1-10 of 24) with videos related to

Pageof 3

Sort By:

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 10, 2018

Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic CancerKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

The Journal of Surgical Research|November 29, 2017

Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancerKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

International Journal of Surgery (London, England)|August 31, 2016

Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data BaseKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

Journal of Gastric Cancer|January 6, 2018

Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United StatesKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

Journal of Gastrointestinal Oncology|November 30, 2017

Prognostic impact of carbohydrate antigen 19-9 level at diagnosis in resected stage I-III pancreatic adenocarcinoma: a U.S. population studyKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

The Journal of Surgical Research|May 15, 2017

Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cmKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

BMJ Case Reports|April 18, 2019

Peritoneal encapsulation: a rare cause of small bowel obstructionAbagayle E Renko, Katelin A Mirkin, Amanda B Cooper

International Journal of Surgery (London, England)|February 10, 2018

Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancerKatelin A Mirkin, Erin K Greenleaf, Christopher S Hollenbeak, et al.

American Journal of Surgery|November 7, 2016

Trends in utilization of neoadjuvant therapy and short-term outcomes in resected pancreatic cancerKatelin A Mirkin, Christopher S Hollenbeak, Niraj J Gusani, et al.

Cancer|June 22, 2016

Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancerKatelin A Mirkin, Erin K Greenleaf, Christopher S Hollenbeak, et al.

Pageof 3

Search research articles

Showing results (1-10 of 24) with videos related to

Sort By:

Pageof 3

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 10, 2018

Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic CancerKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

The Journal of Surgical Research|November 29, 2017

Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancerKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

International Journal of Surgery (London, England)|August 31, 2016

Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data BaseKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

Journal of Gastric Cancer|January 6, 2018

Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United StatesKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

Journal of Gastrointestinal Oncology|November 30, 2017

Prognostic impact of carbohydrate antigen 19-9 level at diagnosis in resected stage I-III pancreatic adenocarcinoma: a U.S. population studyKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

The Journal of Surgical Research|May 15, 2017

Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cmKatelin A Mirkin, Christopher S Hollenbeak, Joyce Wong

BMJ Case Reports|April 18, 2019

Peritoneal encapsulation: a rare cause of small bowel obstructionAbagayle E Renko, Katelin A Mirkin, Amanda B Cooper

International Journal of Surgery (London, England)|February 10, 2018

Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancerKatelin A Mirkin, Erin K Greenleaf, Christopher S Hollenbeak, et al.

American Journal of Surgery|November 7, 2016

Trends in utilization of neoadjuvant therapy and short-term outcomes in resected pancreatic cancerKatelin A Mirkin, Christopher S Hollenbeak, Niraj J Gusani, et al.

Cancer|June 22, 2016

Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancerKatelin A Mirkin, Erin K Greenleaf, Christopher S Hollenbeak, et al.

Pageof 3